TP53 and cancer: Interestingly, normal mammary stem cells with mutations of TP53 possess the same increased self-renewing properties observed in cancer stem cells and promote the formation of mammary preneoplastic lesions; furthermore, pharmacologic reactivation of p53 in cancer stem cells correlated with restored asymmetric divisions and the inhibition of tumor growth [331].